Review: taking Fentanyl and Keppra together


Summary

Drug interactions are reported among people who take Fentanyl and Keppra together. This review analyzes the effectiveness and drug interactions between Fentanyl and Keppra. It is created by eHealthMe based on reports of 340 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Fentanyl and Keppra >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Fentanyl

Fentanyl has active ingredients of fentanyl citrate. It is often used in pain. (latest outcomes from Fentanyl 36,850 users)

Keppra

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from Keppra 24,568 users)

On Aug, 22, 2016

340 people who take Fentanyl, Keppra are studied.


Number of reports submitted per year:

Fentanyl and Keppra drug interactions.

Drug effectiveness over time:

Fentanyl:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Keppra:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Fentanyl:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)
Keppra:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Fentanyl:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Keppra:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • coma
  • drug effect prolonged
  • depressed level of consciousness
  • blood alkaline phosphatase increased
  • blood lactate dehydrogenase increased
  • blood urea increased
  • breast cancer
  • constipation
  • gamma-glutamyltransferase increased
  • neutrophil count increased
1 - 6 months:
  • convulsion
  • loss of consciousness
  • urinary tract infection
  • confusional state
  • hyperhidrosis
  • ventricular tachycardia
  • headache
  • toxic epidermal necrolysis
  • drug toxicity
  • multi-organ failure
6 - 12 months:
  • completed suicide
  • confusional state
  • convulsion
  • headache
  • hyperhidrosis
  • loss of consciousness
  • urinary tract infection
  • ventricular tachycardia
  • application site ulcer
  • drug ineffective
1 - 2 years:
  • anger
  • arachnoiditis
  • asthenia
  • back pain
  • convulsion
  • dental caries
  • diplopia
  • drug dependence
  • drug withdrawal convulsions
  • drug withdrawal syndrome
2 - 5 years:
  • fatigue - chronic
  • gait disturbance
  • migraine with aura
  • nausea
  • pain exacerbated
  • short-term memory loss
  • visual impairment
  • application site discolouration
  • completed suicide
  • drug ineffective
not specified:
  • convulsion
  • pain
  • pneumonia
  • hypotension
  • dyspnoea
  • dehydration
  • respiratory failure
  • oedema peripheral
  • nausea
  • loss of consciousness

Most common drug interactions by gender *:

female:
  • convulsion
  • pain
  • pneumonia
  • dehydration
  • oedema peripheral
  • anxiety
  • injury
  • urinary tract infection
  • loss of consciousness
  • depression
male:
  • convulsion
  • nausea
  • vomiting
  • dyspnoea
  • respiratory failure
  • completed suicide
  • hypotension
  • general physical health deterioration
  • cardiac arrest
  • sepsis

Most common drug interactions by age *:

0-1:
  • drug effect decreased
  • dysgeusia
  • gingival pain
  • glossodynia
  • hypoaesthesia oral
  • paraesthesia oral
  • tongue discolouration
  • anticonvulsant drug level increased
  • bradycardia
  • depressed level of consciousness
2-9:
  • anxiety
  • death
  • emotional distress
  • fear
  • injury
  • multi-organ failure
  • pain
  • renal failure
  • renal impairment
  • renal injury
10-19:
  • dystonia aggravated
  • muscle rigidity
  • dermatitis medicamentosa
  • eosinophilia
  • erythema
  • rash maculo-papular
  • exanthem
  • pulmonary embolism
  • drug eruption
  • skin desquamation
20-29:
  • cardiac arrest
  • completed suicide
  • respiratory arrest
  • acute hepatic failure
  • meningitis
  • pneumonia
  • cardio-respiratory arrest
  • chest discomfort
  • erythema
  • gingival disorder
30-39:
  • convulsion
  • dyspnoea
  • fatigue
  • leukopenia
  • neutropenia
  • pyrexia
  • asthenia
  • back pain
  • cerebrovascular accident
  • dehydration
40-49:
  • convulsion
  • oedema peripheral
  • nausea
  • constipation
  • cyanosis
  • dehydration
  • respiratory arrest
  • alanine aminotransferase increased
  • drug effect decreased
  • fall
50-59:
  • convulsion
  • urinary tract infection
  • loss of consciousness
  • pain
  • depression
  • pneumonia
  • respiratory failure
  • rib fracture
  • injury
  • anxiety
60+:
  • convulsion
  • vomiting
  • hypotension
  • nausea
  • respiratory failure
  • general physical health deterioration
  • sepsis
  • renal failure chronic
  • anaemia
  • fatigue

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Fentanyl and Keppra?


Recent conversations of related support groups:

Can you answer these questions?

More questions for: Fentanyl, Keppra

You may be interested in these reviews

More reviews for: Fentanyl, Keppra

On eHealthMe, Fentanyl (fentanyl citrate) is often used to treat pain. Keppra (levetiracetam) is often used to treat epilepsy. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.